The role of mean platelet volume in metabolic dysfunction associated steatotic liver disease

Documenti analoghi

• Metabolic profiling of tryptophan pathways: Implications for obesity and metabolic dysfunction‐associated steatotic liver disease
  di: Carmen Arto, et al.
  Pubblicazione: (2024)
• Phenotypic patterns of metabolic dysfunction‐associated steatotic liver disease in type 2 diabetes: The impact of insulin
  di: Queralt Martín‐Saladich, et al.
  Pubblicazione: (2025)
• Increased prevalence of high‐risk coronary plaques in metabolic dysfunction associated steatotic liver disease patients: A meta‐analysis
  di: Ovidio De Filippo, et al.
  Pubblicazione: (2024)
• A weekly 4‐methylpyrazole treatment attenuates the development of non‐obese metabolic dysfunction‐associated steatotic liver disease (MASLD) in male mice: Role of JNK
  di: Katharina Burger, et al.
  Pubblicazione: (2024)
• Impact of alcohol consumption on metabolic dysfunction‐associated fatty liver disease development and remission: A longitudinal cohort study
  di: Masahiro Sogabe, et al.
  Pubblicazione: (2024)